Altria relies on cigarettes as vapes face bans, flavors grow and on! competes with ZYN, with low multiple and 7.5% dividend ...

Wall Street has a very short memory, but you shouldn't ignore this worrying trend at Altria.

If there's not a great degree of confidence in its future, then it may not matter a great deal that Altria's payout ratio is ...

Altria Group Inc. urged a Virginia federal judge to immediately shut down a probe seeking to block imports of its NJoy units’ ...

If you are wondering whether Altria Group's share price reflects its true worth today, you are not alone and this article is ...

Altria (MO) offers a contrarian buy setup: near $55 support with rebound signals, plus ~10x P/E and strong profitability for ...

Altria (MO) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the ...

By comparison, Target's 4.5% yield looks far more attractive, noting that it also comes along with a roughly 55% dividend ...

SILVER SPRING, Md. — The U.S. Food and Drug Administration (FDA) authorized the marketing for six nicotine pouch products ...

The WisdomTree U.S. High Dividend Fund (NYSEARCA:DHS) offers retirees monthly income and capital appreciation. With $1.3 ...

Altria stock (NYSE: MO) currently trades at $45 per share, around 20% below its level of $57 on May 7, 2022 (pre-inflation shock high), and it seems like it has the potential for sizable gains. Altria ...

Altria bought a 45% stake in Cronos Group for $1.8 billion in 2021. The marijuana market has collapsed due to regulatory snafus in Canada and slow-walking legalization in the U.S. Altria has better ...